U.S. Supreme Court Allows Racketeering Lawsuit Against Takeda and Lilly Over Actos

The U.S. Supreme Court has permitted a multibillion-dollar racketeering lawsuit to proceed against pharmaceutical companies Takeda and Lilly. Bloomberg posted on X, highlighting that the lawsuit accuses the companies of marketing the diabetes drug Actos without revealing its potential link to bladder cancer. This decision marks a significant development in the legal battle surrounding Actos, which has been the subject of numerous lawsuits over its safety. The plaintiffs allege that Takeda and Lilly engaged in deceptive practices by failing to disclose the risks associated with the drug, leading to widespread harm among consumers. The case will now move forward in the legal system, potentially resulting in substantial financial repercussions for the companies involved.